309 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
Rank Status Study
1 Recruiting A Phase 2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
Conditions: Locally Advanced or Metastatic Urothelial Cell Carcinoma;   Urinary Bladder Disease;   Urological Diseases
Interventions: Drug: B-701;   Drug: Docetaxel;   Drug: placebo
2 Recruiting A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Conditions: Overactive Bladder;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: mirabegron;   Drug: antimuscarinic medication
3 Recruiting A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Intervention: Drug: Betmiga®
4 Recruiting This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases\Urologic Diseases
Interventions: Drug: Solifenacin Succinate;   Drug: Mirabegron;   Drug: Placebo
5 Not yet recruiting 3D HD Versus 2D HD in Cholecystectomy
Conditions: Cholelithiasis;   Gall Bladder Disease
Interventions: Device: 3D HD laparoscopy;   Device: 2D HD laparoscopy
6 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
7 Not yet recruiting Vicinium Treatment for Subjects With High-grade Non-muscle Invasive Bladder Cancer Previously Treated With BCG
Condition: Bladder Cancer
Intervention: Biological: Vicinium
8 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
Intervention:
9 Recruiting Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Enzalutamide;   Drug: Cisplatin;   Drug: Gemcitabine
10 Recruiting Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC
Condition: Carcinoma of Urinary Bladder, Superficial
Interventions: Device: 40 mg MMC gel;   Other: Standard of care MMC mixed with water;   Device: 80 mg MMC gel
11 Not yet recruiting A Trial of Transcutaneous Nerve Stimulation for OAB
Condition: Overactive Bladder
Interventions: Other: Transcutaneous tibial nerve stimulation;   Other: Sham transcutaneous tibial nerve stimulation
12 Recruiting Overactive Bladder Education
Conditions: Urinary Bladder, Overactive;   Urinary Incontinence, Urge
Intervention: Other: Overactive Bladder Care Plan counseling
13 Recruiting The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse Repair
Conditions: Overactive Bladder;   Pelvic Organ Prolapse
Intervention:
14 Recruiting Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.
Condition: Urinary Bladder, Neurogenic
Interventions: Drug: Fesoterodine PR 4 mg;   Drug: Fesoterodine PR 8 mg;   Drug: Fesoterodine BIC 2 mg;   Drug: Fesoterodine BIC 4 mg
15 Not yet recruiting Testing the PD-1 Inhibitor Pembrolizumab After Initial Chemotherapy in Patients With Metastatic Bladder Cancer
Conditions: Urothelial Cancer;   Bladder Cancer
Interventions: Other: Placebo;   Drug: Pembrolizumab
16 Not yet recruiting Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis
Condition: Cystitis, Interstitial
Interventions: Biological: Certolizumab pegol;   Drug: Placebo
17 Not yet recruiting Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan
Conditions: Prostatic Hyperplasia;   Kidney Calculi;   Bladder Tumors
Intervention: Device: Aqueduct
18 Recruiting Cabozantinib Plus Nivolumab (CaboNivo) Alone or in Combination With Ipilimumab (CaboNivoIpi) in Patients With Advanced/Metastatic Urothelial Carcinoma and Other Genitourinary Tumors
Conditions: Urothelial Cancer;   Bladder Cancer;   Genitourinary Cancer;   Urogenital Neoplasms;   Urogenital Cancer
Interventions: Drug: Cabozantinib;   Drug: Nivolumab;   Drug: Ipilimumab
19 Not yet recruiting Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer
Conditions: Bladder Papillary Urothelial Carcinoma;   Stage 0a Bladder Urothelial Carcinoma;   Stage 0is Bladder Urothelial Carcinoma;   Stage I Bladder Cancer With Carcinoma In Situ;   Stage I Bladder Urothelial Carcinoma;   Stage II Bladder Urothelial Carcinoma;   Stage III Bladder Urothelial Carcinoma;   Stage IV Bladder Urothelial Carcinoma
Intervention: Other: Laboratory Biomarker Analysis
20 Not yet recruiting The PK Characteristics of the JLP-1207(Solifenacin/Tamsulosin 5mg/0.2mg) and Co-administration of Solifenacin and Tamsulosin in Healthy Male Volunteers.
Conditions: LUTS(Lower Urinary Tract Symptoms);   Benign Prostatic Hyperplasia;   Overactive Bladder
Interventions: Drug: JLP-1207;   Drug: Solifenacin 5mg + Tamsulosin 0.2mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years